Procurement of Sonosite LX Ultrasound System (Brand Name restriction)

HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH - CC is soliciting Procurement of Sonosite LX Ultrasound System (Brand Name restriction). Solicitation number RFQ-26-008281. Classified under NAICS 334510 — Electromedical and Electrotherapeutic Apparatus Manufacturing. Product/service code 6525 — IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY. Place of performance: MD, USA. Responses are due by 28 September 2026 14:00 UTC. Posted on SAM.gov, the US federal contract opportunities system; registration is required to bid.

Acquisition Description:

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-04. The Solicitation number is RFQ-26-008281 and the solicitation is issued as a Request for Quotes (RFQ).

Acquisition Description & Justification:

The National Institutes of Health (NIH) Clinical Center requires the acquisition of a FUJIFILM Sonosite LX Point-of-Care Ultrasound (POCUS) System with multiple transducers to support pediatric critical care imaging. The system includes advanced diagnostic imaging capabilities, Color and Spectral Doppler, Tissue Harmonic Imaging, DICOM connectivity, wireless networking, integrated educational resources, manufacturer installation and training, and a five-year comprehensive warranty. The acquisition also includes specialty transducers to support cardiac, abdominal, pulmonary, vascular access, musculoskeletal, neonatal, and pediatric imaging applications.

Justification:

The Sonosite LX will provide clinicians with high-quality, real-time bedside imaging necessary for the care of critically ill pediatric patients in the Pediatric Intensive Care Unit (PICU). The system supports rapid diagnosis and ultrasound-guided procedures, including vascular access, cardiac assessments, pulmonary evaluations, abdominal imaging, and other point-of-care applications. Its portability, exceptional image quality, intuitive touchscreen workflow, advanced needle visualization technology, and comprehensive imaging capabilities enable timely clinical decision-making, improve procedural success, reduce complications, and enhance patient safety. The inclusion of multiple transducers allows a single platform to support a broad range of pediatric and critical care examinations, maximizing clinical utility while minimizing equipment redundancy. The five-year manufacturer warranty and onsite clinical training further ensure long-term reliability and successful implementation. FUJIFILM Sonosite is a recognized industry leader in point-of-care ultrasound technology with extensive experience supporting hospitals and critical care environments. The vendor offers the complete Sonosite LX platform, manufacturer-certified installation, clinical education, technical support, and a comprehensive five-year warranty for both the ultrasound system and transducers. The proposed equipment is available through an existing federal contract, ensuring compliance with federal procurement requirements while providing access to factory-authorized service, software updates, replacement components, and ongoing technical support. As the original equipment manufacturer, FUJIFILM Sonosite is uniquely qualified to provide the equipment, warranty coverage, training, and lifecycle support necessary to maintain safe and reliable operation in the NIH Clinical Center's Pediatric Intensive Care Unit. Only this specific brand of equipment from Fujitsu Sonosite can be accepted. Vendors must be authorized resellers and provide their letter of authorization.

Place of Performance or Delivery:

The Period of Performance is:

09/28/2026 – 09/27/2027 Delivery within 30 days of award, or as otherwise mutually agreed to

Place of Performance/Delivery: NIH Clinical Center in Bethesda, MD

------------------------------------------------------------------------------------------------------------------------------------------------------------ The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (SEPT 2023) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (DEC 2022) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017) 52.204–26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (DEC 2022) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (SEP 2023) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm. ---------------------------------------------------------------------------------------------------------------------------------- By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. The government intends to award a “firm fixed price” order (in the form of a PO, IDIQ, or BPA) to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The government will evaluate quotes to determine the proposal that conforms to the solicitation and presents the best value to the government (eg. the most advantageous to the Government based on price, performance, availability of funds, etc.). The award will be made based on technical capability to meet the requirements/technical factors, price, and past performance. Submission shall be received not later than 09/28/2026 by @ 10:00 AM EST. Offers may be emailed to Lu Chang at <[contact details removed]> by the date and time stated above. Late submission shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via email to the respective contacts above. Offers shall include RFQ number in the subject line (RFQ-26-008281). Offers shall also include the price, delivery timeframes, and any other required documentation/information as mentioned above. Offers that do not meet these requirements may be excluded from consideration.